GSK-3389404

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameGSK-3389404
Drug Alias NameIONIS-GSK6-LRxISIS-GSK6-LRxIONIS-HBV-LRxGSK-3389404
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionViral proteins inhibitors
TargetsViral proteins
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeTaiwanThailand +[9] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGlaxosmithkline Manufacturing SpaGlaxo Group Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A